100
Participants
Start Date
June 5, 2016
Primary Completion Date
January 13, 2021
Study Completion Date
June 25, 2021
Debio 1562
Administered as IV Infusion.
Rituximab
Administered as IV Infusion.
Specialized Hospital for Active Treatment of Hematological Diseases,Clinic of Hematology, Sofia
St. Augustinus Hospital, Department of Hematology, Wilrijk
University Hospitals Leuven, Campus Gasthuisberg, Leuven
Multiprofile Hospital for Active Treatment - Hristo Botev, Vratsa, Vratsa
"University Multiprofile Hospital for Active Treatment Sveti Georgi", Plovdiv
University of Debrecen Clinical Center, Debrecen
CHU UCL Namur asbl - Site Godinne, Yvoir
Regional Hospital of Bellinzona and Valli, Oncology Institute of Southern Switzerland, Bellinzona
Jan Yperman Ziekenhuis, Ieper
Cherkasy Regional Oncology Center, Regional Treatment and Diagnostic Hematology Center, Cherkasy
Abramson Cancer Center of The University of Pennsylvania, Philadelphia
Podillia Regional Oncology Center, Vinnytsia
Civil Hospital of Brescia, Brescia
Novant Health Oncology, Winston-Salem
Spartanburg Regional Healthcare System, Spartanburg
Alabama Oncology, Birmingham
Local Healthcare Company 8 Berica (Azienda ULSS8 Berica), Hospital San Bortolo of Vicenza, Vicenza
Cleveland Clinic, Cleveland
Abbott Northwestern Hospital, Virginia Piper Cancer Institute, Minneapolis
University Hospital - Ospedali Riuniti Umberto I - GM Lancisi - G Salesi of Ancona, Ancona
Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine, Kharkiv
"Communal Non-profit enterprise Regional Center of Oncology", Kharkiv
Carle Foundation Hospital, Cancer Center, Urbana
Baylor University Medical Center, Dallas
United Hospitals Villa Sofia Cervello, Palermo
Swedish Medical Center, Seattle
University Hospital Brno, Brno
University Hospital Hradec Kralove, Hradec Králové
University Hospital Kralovske Vinohrady, Prague
General University Hospital in Prague, Prague
National Institute of Oncology, Budapest
Medical Center of the University of Pecs, Pécs
University Clinical Center in Gdansk, Gdansk
Provincial Hospitals in Gdynia Sp. z o.o. (LLC), Gdynia
Małopolskie Medical Centre, Krakow
St. John of Dukla Oncology Center of Lublin Land, Lublin
National Institute of Cancer, Kyiv
National Research Center for Radiation Medicine, Kyiv
Kyiv City Clinical Hospital #9, City Hematology Center, Kyiv
Lead Sponsor
Debiopharm International SA
INDUSTRY